Neurofibromatosis Report
Neurofibromatosis
Neurofibromatosis is a hereditary condition characterized by the onset of benign tumors, called neurofibromas, along the course of the nerves. The two main types differ clinically and genetically, although they belong to the same nosological entity. The genetic alterations underlying Neurofibromatosis compromise the tumor suppressor function of the genes involved, thus opening the way to uncontrolled cell proliferation.
5 genes analyzed genes analyzed
It is recommended if:
This report supports the diagnosis of Neurofibromatosis, which generally occurs in adulthood, but is also useful for those who have a positive family history for the pathology (this is the main risk factor).
List of main conditions:
- Neurofibromatosis type 1/2
- Schwannomatosis
Additional Reports
Choose a report's category:
FAQs
How will my data be used?
Your data is yours. Which is why we have developed proprietary software linked to a dedicated platform, the Genome Manager, to provide you with unique access to your data whenever you want, wherever you are.
How can my doctor use the results?
You will be provided with a digital version of the raw data and reports. Thanks to these in-depth tools, you will be able to share your preferred information with your geneticist and/or doctor to indicate and plan the healthiest course for you.
How will I receive my reports?
The first thing to do when you receive your kit is to register it on your Genome Manager account. Dante's proprietary platform will keep you up-to-date on all stages of your genetic journey, providing you with the real-time status of your sample and where you can download your free report and raw data* at any time.
*Raw data will be available free of charge for the first 30 days after release.
How can I add other reports to my account?
At any time, you can log into your Genome Manager account and visit the Shop section. Here you will find a catalog with more than 150 additional reports dedicated to all areas of health. In addition, by subscribing to our newsletter you can always see new reports and panel updates.
Our Certifications
